Fig. 7.

Cytotoxicity of NK92 cells to HepG2 cells following treatment with efavirenz and efavirenz solid drug nanoparticles. NK92 cells were treated with either efavirenz aqueous solution (a) or efavirenz s (b) for 24 h before their cytotoxic capability was assessed